MSWA
MRNA icon

Marshall & Sterling Wealth Advisors’s Moderna MRNA Stock Holding History

Marshall & Sterling Wealth Advisors’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-10
Closed -$258 – 520
2025
Q3 		$258 Hold
10
– – ﹤0.01% 635
2025
Q2 		$276 Sell
10
-725
-99% -$19.1K ﹤0.01% 617
2025
Q1 		$20.8K Buy
735
+725
+7,250% +$25.7K 0.01% 247
2024
Q4 		$416 Buy
+10
New +$478 ﹤0.01% 346

Other funds holding MRNA

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Marshall & Sterling Wealth Advisors's MRNA Position: Q4 2025 in Review

Marshall & Sterling Wealth Advisors sold out of Moderna (MRNA) in Q4 2025, closing a stake of 10 shares — an estimated $258 sold.

Marshall & Sterling Wealth Advisors first reported a position in MRNA in Q4 2024 and held it in 4 quarters. The position peaked at $20.8K in Q1 2025. 675 funds tracked by Wall St. Rank hold MRNA as of Q4 2025.

  • Marshall & Sterling Wealth Advisors reported no remaining Moderna position as of Q4 2025 after selling out during the quarter.
  • Marshall & Sterling Wealth Advisors sold 10 Moderna shares in Q4 2025, an estimated $258.
  • Marshall & Sterling Wealth Advisors first reported a position in Moderna in Q4 2024 and held it in 4 quarters.
  • Marshall & Sterling Wealth Advisors's Moderna position peaked at $20.8K in Q1 2025.
  • 675 funds tracked by Wall St. Rank held Moderna as of Q4 2025.

Based on Marshall & Sterling Wealth Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.